Hepatitis B and End-Stage Liver Disease

Ilan S. Weisberg; Robert S. Brown; Samuel H. Sigal

doi:10.1016/j.cld.2007.08.009

Hepatitis B and End-Stage Liver Disease

Ilan S. Weisberg
, Robert S. Brown
, Samuel H. Sigal

Research output: Contribution to journal › Review article › peer-review

15 Scopus citations

Abstract

Hepatitis B virus (HBV) is the most common cause of chronic hepatitis and end-stage liver disease worldwide. Untreated, chronic hepatitis B acquired early in life results in cirrhosis, liver failure, or hepatocellular carcinoma in up to 40% of individuals. Until recently, the options for a patient who had end-stage hepatitis B cirrhosis were severely limited, but during the past 15 years great strides have been made in prevention and treatment of hepatitis B cirrhosis. This article reviews recent advances in the understanding of the natural history, prevention, and medical management of HBV-related end-stage liver disease.

Original language	English (US)
Pages (from-to)	893-916
Number of pages	24
Journal	Clinics in Liver Disease
Volume	11
Issue number	4
DOIs	https://doi.org/10.1016/j.cld.2007.08.009
State	Published - Nov 2007
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Hepatology

Access to Document

10.1016/j.cld.2007.08.009

Cite this

@article{1800ed0367734f3cb9e71b76b7a7335c,

title = "Hepatitis B and End-Stage Liver Disease",

abstract = "Hepatitis B virus (HBV) is the most common cause of chronic hepatitis and end-stage liver disease worldwide. Untreated, chronic hepatitis B acquired early in life results in cirrhosis, liver failure, or hepatocellular carcinoma in up to 40\% of individuals. Until recently, the options for a patient who had end-stage hepatitis B cirrhosis were severely limited, but during the past 15 years great strides have been made in prevention and treatment of hepatitis B cirrhosis. This article reviews recent advances in the understanding of the natural history, prevention, and medical management of HBV-related end-stage liver disease.",

author = "Weisberg, \{Ilan S.\} and Brown, \{Robert S.\} and Sigal, \{Samuel H.\}",

year = "2007",

month = nov,

doi = "10.1016/j.cld.2007.08.009",

language = "English (US)",

volume = "11",

pages = "893--916",

journal = "Clinics in Liver Disease",

issn = "1089-3261",

publisher = "W.B. Saunders",

number = "4",

}

TY - JOUR

T1 - Hepatitis B and End-Stage Liver Disease

AU - Weisberg, Ilan S.

AU - Brown, Robert S.

AU - Sigal, Samuel H.

PY - 2007/11

Y1 - 2007/11

N2 - Hepatitis B virus (HBV) is the most common cause of chronic hepatitis and end-stage liver disease worldwide. Untreated, chronic hepatitis B acquired early in life results in cirrhosis, liver failure, or hepatocellular carcinoma in up to 40% of individuals. Until recently, the options for a patient who had end-stage hepatitis B cirrhosis were severely limited, but during the past 15 years great strides have been made in prevention and treatment of hepatitis B cirrhosis. This article reviews recent advances in the understanding of the natural history, prevention, and medical management of HBV-related end-stage liver disease.

AB - Hepatitis B virus (HBV) is the most common cause of chronic hepatitis and end-stage liver disease worldwide. Untreated, chronic hepatitis B acquired early in life results in cirrhosis, liver failure, or hepatocellular carcinoma in up to 40% of individuals. Until recently, the options for a patient who had end-stage hepatitis B cirrhosis were severely limited, but during the past 15 years great strides have been made in prevention and treatment of hepatitis B cirrhosis. This article reviews recent advances in the understanding of the natural history, prevention, and medical management of HBV-related end-stage liver disease.

UR - https://www.scopus.com/pages/publications/35548946090

UR - https://www.scopus.com/pages/publications/35548946090#tab=citedBy

U2 - 10.1016/j.cld.2007.08.009

DO - 10.1016/j.cld.2007.08.009

M3 - Review article

C2 - 17981234

AN - SCOPUS:35548946090

SN - 1089-3261

VL - 11

SP - 893

EP - 916

JO - Clinics in Liver Disease

JF - Clinics in Liver Disease

IS - 4

ER -

Hepatitis B and End-Stage Liver Disease

Abstract

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this